Skip to main content

Peer Review reports

From: Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry

Original Submission
30 Jan 2020 Submitted Original manuscript
18 Feb 2020 Author responded Author comments - Proton Rahman
Resubmission - Version 2
18 Feb 2020 Submitted Manuscript version 2
16 Mar 2020 Reviewed Reviewer Report - Gregory Gardner
25 Mar 2020 Reviewed Reviewer Report - Naoki Iwamoto
26 Mar 2020 Reviewed Reviewer Report
29 Apr 2020 Author responded Author comments - Proton Rahman
Resubmission - Version 3
29 Apr 2020 Submitted Manuscript version 3
5 May 2020 Reviewed Reviewer Report - Gregory Gardner
20 May 2020 Reviewed Reviewer Report - Naoki Iwamoto
26 May 2020 Reviewed Reviewer Report
1 Jun 2020 Author responded Author comments - Proton Rahman
Resubmission - Version 4
1 Jun 2020 Submitted Manuscript version 4
Publishing
3 Jun 2020 Editorially accepted
19 Sep 2020 Article published 10.1186/s41927-020-00145-4

You can find further information about peer review here.

Back to article page